We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
NORVIR Abbvie Pty Ltd
Product name
NORVIR
Sponsor
Accepted date
Oct-2025
Active ingredients
ritonavir
Summary of proposed indication
Norvir (ritonavir) is proposed to be used together with other HIV medicines to increase their effectiveness. It is proposed to be used in adults and children aged 12 and over who have HIV-1.
Application type
C (new indication)
Publication date
Oct-2025